## **Run overview**


| **Metric**        | **Value**                                                     |
| ----------------- | ------------------------------------------------------------- |
| **Total runtime** | **2h 51m 21s** (171m 20s per header)                          |
| **Workflow**      | TEM-1 activity screen, 9 compounds + controls, 33 assay wells |
| **Started**       | 2026-07-25 23:04:32 PDT                                       |
| **Completed**     | 2026-07-26 01:55:53 PDT                                       |


---

## **Time budget (major phases)**


| **Phase**                               | **Duration** | **% of run** |
| --------------------------------------- | ------------ | ------------ |
| Setup (pipette + dilutions)             | **1h 16m**   | 45%          |
| Assay plate loading (TEM-1 + compounds) | **43m**      | 25%          |
| Plate mix + shaker handling             | **12m**      | 7%           |
| Pre-incubation (logged)                 | **2m**       | 1%           |
| **Nitrocefin prep + dispense**          | **36m**      | **21%**      |


Within dilutions, **~31 min is an unlogged wait** (23:50 → 00:21) — likely compound solubilization/DMSO equilibration, but not labeled as such.

---

## **Dispense times between steps**

### **Serial liquid transfers (Prepare Dilutions)**


| **Step**                                          | **Time**            | **Δ from prior**                |
| ------------------------------------------------- | ------------------- | ------------------------------- |
| TEM-1 stock → intermediate (2 µL)                 | 23:05:22            | —                               |
| BLB → TEM-1 intermediate, chunk 1 (120 µL)        | 23:07:22            | 2m 0s                           |
| BLB → TEM-1 intermediate, chunk 2 (78 µL)         | 23:08:25            | **1m 3s**                       |
| TEM-1 intermediate → working (100 µL)             | 23:12:58            | 4m 33s *(tip swap + move)*      |
| BLB → working, chunks 1–8 (120 µL each)           | 23:14:00 – 23:21:12 | **~1m 1–2s each**               |
| BLB → T1262 intermediate (49 µL)                  | 23:25:30            | 4m 18s                          |
| T1262 stock → intermediate (1 µL)                 | 23:27:31            | 2m 1s                           |
| BLB batch → PCR plate (10 wells, 47.5 µL)         | 23:32:25 – 23:38:14 | **~69s per 2-well batch**       |
| BLB → vehicle well A2 (95 µL)                     | 23:38:34            | 56s block                       |
| Serial 10-fold dilutions (pos ctrl + 9 compounds) | 23:40:28 – 23:49:38 | **~54–55s per 2.5 µL transfer** |
| **Unlogged incubation**                           | 23:50:16 – 00:20:59 | **~31 min**                     |


### **Assay plate loading (00:21 – 01:04)**


| **Step**                                 | **Duration**       | **Notes**                                               |
| ---------------------------------------- | ------------------ | ------------------------------------------------------- |
| TEM-1 → 33 wells (20 µL, 6-well batches) | **13m 14s**        | ~2m 0s per 6-well batch                                 |
| No-enzyme BLB → 3 wells                  | **1m 24s**         |                                                         |
| Vehicle DMSO → 6 wells                   | **4m 30s**         | 3 batches × ~1m 4s                                      |
| Positive control → 3 wells               | **2m 7s**          |                                                         |
| Test compounds 1–9 → 3 wells each        | **~2m 8–12s each** | Compound 1 outlier: **3m 58s** (2m gap between batches) |


Typical **5 µL compound dispense cycle**: Batch 1 (~21s to first dispense) → Batch 2 (~1m 11s later) → complete (~36s cleanup) ≈ **~2m 8s total**.

### **Nitrocefin phase (01:19 – 01:56)**

**Preparation (01:19:45 – 01:38:49): 19m 4s**


| **Sub-step**                                    | **Duration**                     |
| ----------------------------------------------- | -------------------------------- |
| BLB chunks 1–11 into hole_10 (1243.75 µL total) | ~13m *(~1m 3s per 120 µL chunk)* |
| Nitrocefin stock (6.25 µL)                      | 23:33:54                         |
| Post-stock wait / move                          | ~3m 8s                           |
| **Total prep**                                  | **19m 4s**                       |


**Dispense to assay (01:38:49 – 01:55:52): 17m 3s**

Each condition (3 wells × 25 µL) takes **~1m 22–24s**, very consistent:


| **Condition**               | **Duration**   |
| --------------------------- | -------------- |
| No-enzyme control           | 1m 24s         |
| Positive control            | 1m 24s         |
| Compounds 1–9               | 1m 22–24s each |
| Vehicle control             | 1m 34s         |
| **12 conditions × ~1m 24s** | **~17m total** |


Within each nitrocefin dispense: **~19s** to aspirate/dispense 3 wells, **~45–65s** overhead (tip, travel, batch setup).

---

## **Nitrocefin assay timing summary**


| **Component**                            | **Time**   |
| ---------------------------------------- | ---------- |
| Solution prep (1250 µL @ 100 µM)         | 19m 4s     |
| Dispense to 36 wells (12 conditions × 3) | 17m 3s     |
| **Total nitrocefin phase**               | **36m 7s** |


Critical path concern: nitrocefin is prepared **after** a 2 min pre-incubation, then takes another **19 min** before the first well receives substrate. That is **~21 min** from pre-incubation end to first nitrocefin addition — potentially problematic for nitrocefin stability and reaction timing consistency across wells.

---

## **Log format assessment**

**What works well**

- Clear hierarchical structure: top-level steps vs indented detail lines
- Good metadata header (execution ID, workflow, total duration)
- Batched dispense summaries are excellent (`✓ Batched dispense … 33 wells, 6 aspirate batch(es)`)
- Volumes, source/dest, tip numbers, and well IDs are all logged
- Explicit wait blocks where present (`waiting 1 minute`, `waiting 2 minute`)

**Pain points**

1. **Massive duplicate** `STARTING` **spam** — same step logged dozens of times (e.g. "Prepare Dilutions STARTING" appears ~80+ times). Makes the log ~3× longer than needed and obscures real events.
2. **No delta/elapsed times** — you must diff timestamps manually.
3. **Silent incubations** — the 31 min dilution wait has no "waiting X minutes" line; only cryptic STARTING pings every ~2m 36s.
4. **Inconsistent granularity** — some steps have rich batch detail, others are black boxes (shaker handling, plate moves).
5. **Midnight rollover** — timestamps lack date, fine for a single run but fragile for multi-day logs.
6. **No phase-level summary at end** — would be valuable for post-run QC.

---

## **General timewise analysis**

The run is **robot-motion bound**, not biochemistry bound:

- **~62s per 120 µL serial transfer** (tip pick + move + aspirate + dispense + eject) dominates dilution prep.
- **~2m per compound** for 3 × 5 µL transfers is slow relative to the liquid volume moved — overhead is tip changes and deck travel between PCR source plate and assay plate.
- **TEM-1 loading (13m for 33 × 20 µL)** is the single longest contiguous dispense block.
- **Nitrocefin is the second-largest time sink (21% of run)** and is split inefficiently: 19 min prep + 17 min dispense, done sequentially per condition rather than batched across all wells at once.
- **Shaker/plate handling (~12 min)** for a 1 min mix is high overhead — likely unavoidable with current hardware but worth noting.
- The **31 min hidden incubation** is the largest single "dead time" and isn't attributed in the time budget unless you infer it.

Rough throughput: **~2h 51m for 9-compound screen** ≈ **19 min/compound** all-in, or **~5 min/compound** if you exclude setup and nitrocefin prep (which could be amortized).

---

## **Recommended improvements**

### **High impact (time)**

1. **Pre-prepare nitrocefin during pre-incubation or earlier** — overlap the 19 min BLB+stock prep with the 2 min pre-incubation + plate mix window. Could save **~15–17 min** and reduce substrate degradation risk.
2. **Single batched nitrocefin dispense to all 36 wells** — you're configured for 4 wells/aspiration but dispatch one condition at a time. One batch covering all wells (or 6 batches of 6) could cut dispense from **17m → ~4–5m**.
3. **Fix Compound 1 anomaly** — 2m dead gap between batches (00:42:39 → 00:45:40) vs ~1m 12s for others. Likely a retry, pause, or deck collision; worth investigating.
4. **Reduce serial BLB chunks** — 11 × 120 µL transfers for nitrocefin prep (~13 min) could use a larger-volume approach or pre-aliquoted buffer if the deck allows.
5. **Increase compound batch size** — vehicle uses 2 wells/aspiration; compounds use 2 then 1. A consistent 3-well single aspiration (you already aspirate 10 µL for 2 × 5 µL) would save one tip cycle per compound (~9 min across 9 compounds).

### **Log format**

1. **Log each step once** on start, once on complete — suppress polling STARTING repeats.
2. **Add explicit incubation timers** for the 31 min dilution wait (and label purpose: e.g. "DMSO equilibration").
3. **Auto-compute** `+Δ` **elapsed** on detail lines.
4. **End-of-run phase summary table** (like the time budget above).
5. **Flag gaps >60s** without a logged action as `⚠ idle gap`.

### **Assay design / biology**

1. **Stagger nitrocefin addition intentionally or minimize it** — current ~84s spread across 12 conditions means wells 1 and 12 differ by ~17 min in reaction start time. Either batch all at once or document/accept the stagger for kinetics analysis.
2. **Consider preparing nitrocefin working solution off-deck** (manual or pre-run) given its instability — the log itself says "proceed immediately to assay wells" but prep takes 19 min.

---

